NASDAQ:VIVO
Delisted
Meridian Bioscience Inc. Stock News
$33.97
+0 (+0%)
At Close: Apr 28, 2023
Medical Devices Stock Pumps Up Buy Point With New Innovations
05:15pm, Thursday, 17'th Nov 2022
After launching three new products and posting a second quarter of rising EPS growth, medical devices leader Merit Medical Systems is probing a new buy point. The post Medical Devices Stock Pumps Up B
4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire
06:25am, Friday, 07'th Oct 2022
This quartet of stocks has plenty of growth ahead and is already profitable.
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?
10:20am, Thursday, 15'th Sep 2022 Zacks Investment Research
Sector ETF report for XHE
Meridian Bioscience (VIVO) Meets Q3 Earnings Estimates
01:25pm, Friday, 05'th Aug 2022 Zacks Investment Research
Meridian Bioscience (VIVO) delivered earnings and revenue surprises of 0% and 1.45%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Generation Bio Co. (GBIO) Reports Q2 Loss, Misses Revenue Estimates
09:45pm, Thursday, 04'th Aug 2022 Zacks Investment Research
Generation Bio Co. (GBIO) delivered earnings and revenue surprises of -4.76% and 100%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Is SPDR S&P Health Care Equipment ETF (XHE) a Strong ETF Right Now?
10:20am, Wednesday, 03'rd Aug 2022 Zacks Investment Research
Smart Beta ETF report for XHE
Analysts Estimate Meridian Bioscience (VIVO) to Report a Decline in Earnings: What to Look Out for
02:00pm, Friday, 29'th Jul 2022 Zacks Investment Research
Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Meridian Bioscience (VIVO) to Report a Decline in Earnings: What to Look Out for
12:26pm, Friday, 29'th Jul 2022
Meridian Bioscience (VIVO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022
02:02pm, Friday, 08'th Jul 2022 Benzinga
Upgrades
According to Wedbush, the prior rating for Diebold Nixdorf Inc (NYSE:DBD) was changed from Neutral to Outperform. Diebold Nixdorf earned $1.61 in the first quarter, compared to $0.29 in the
Meridian Biosciences (VIVO) Stock Trending on $1.5 Billion Buyout Agreement
10:52am, Thursday, 07'th Jul 2022
VIVO stock is a hot topic on Wall Street today, not just because Meridian Biosciences released a fiscal update, but also due to takeover news. The post Meridian Biosciences (VIVO) Stock Trending on $1
Meridian Bioscience agrees to $1.5 billion buyout by SD Biosensor, SJL Partners
07:32am, Thursday, 07'th Jul 2022
Meridian Bioscience Inc. VIVO, +7.02% announced an agreement Thursday to be acquired by a consortium of South Korea-based SD Biosensor Inc. 137310, +2.08% and private equity firm SJL Partners LLC in a
Meridian Bioscience Is Not Your Average Life Science Company
10:15pm, Tuesday, 05'th Jul 2022
100% technical buy signals. 8 new highs and up 15.79% in the last month.
Meridian Bioscience (VIVO) Moves 5.7% Higher: Will This Strength Last?
08:49am, Monday, 20'th Jun 2022 Zacks Investment Research
Meridian Bioscience (VIVO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the ne
Meridian Bioscience (VIVO) Moves 5.7% Higher: Will This Strength Last?
07:48am, Monday, 20'th Jun 2022
Meridian Bioscience (VIVO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the ne
Meridian Bioscience to Participate in the 2022 H.C. Wainwright Global Investment Conference
01:13pm, Monday, 23'rd May 2022
CINCINNATI , May 23, 2022 /PRNewswire/ -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading global provider of diagnostic testing solutions and life science raw materials, announced today its part
